Spectrum Pharmaceuticals Inc (SPPI)

3.03 +0.09  +3.06% NASDAQ Jun 1, 17:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 16:30 EDT Misc Spectrum Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Spectrum Pharmaceuticals Inc Second Quarter Earnings in 2020 Release
06/18/2020 10:00 PDT Misc Spectrum Pharmaceuticals Inc Annual General Meeting for 2019
05/07/2020 16:30 EDT Misc Spectrum Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
05/07/2020 Earnings Spectrum Pharmaceuticals Inc First Quarter Earnings Result for 2020
03/02/2020 Misc Spectrum Pharmaceuticals Inc Annual Report for 2019
02/27/2020 16:30 EST Misc Spectrum Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
02/27/2020 Earnings Spectrum Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
11/07/2019 16:30 EST Misc Spectrum Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2019
11/07/2019 Earnings Spectrum Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.sppirx.com
  • Investor Relations URL: http://investor.sppirx.com/index.cfm
  • HQ State/Province: Nevada
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: May. 07, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 18, 2012
  • Description: Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. Its other products include FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.